Discontinuation of Tyrosine Kinase Inhibitor in Children with Chronic Myeloid Leukemia (JPLSG STKI-14 study)

Haruko Shima, Akiko Kada, Akihiko Tanizawa, Yuki Yuza, Akihiro Watanabe, Masaki Ito, Hideko Uryu, Katsuyoshi Koh, Chihaya Imai, Nao Yoshida, Yuhki Koga, Naoto Fujita, Akiko M. Saito, Souichi Adachi, Eiichi Ishii, Hiroyuki Shimada

Research output: Contribution to journal › Article

Abstract

DISCLOSURES: Kada: Bayer Yakuhin: Other: personal fees for a member of independent data monitoring committee of clinical trials, outside of the submitted work.. Imai:Juno Therapeutics: Patents & Royalties.

Original languageEnglish
Number of pages1
JournalBlood
Volume134
Issue number1
DOIs
Publication statusPublished - 2019 Nov 13

Fingerprint

Clinical Trials Data Monitoring Committees
Patents
Fees and Charges
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
Protein-Tyrosine Kinases
Monitoring
Therapeutics

ASJC Scopus subject areas

  • Biochemistry
  • Immunology
  • Hematology
  • Cell Biology

Cite this

Discontinuation of Tyrosine Kinase Inhibitor in Children with Chronic Myeloid Leukemia (JPLSG STKI-14 study). / Shima, Haruko; Kada, Akiko; Tanizawa, Akihiko; Yuza, Yuki; Watanabe, Akihiro; Ito, Masaki; Uryu, Hideko; Koh, Katsuyoshi; Imai, Chihaya; Yoshida, Nao; Koga, Yuhki; Fujita, Naoto; Saito, Akiko M.; Adachi, Souichi; Ishii, Eiichi; Shimada, Hiroyuki.

In: Blood, Vol. 134, No. 1, 13.11.2019.

Research output: Contribution to journal › Article

Shima, H, Kada, A, Tanizawa, A, Yuza, Y, Watanabe, A, Ito, M, Uryu, H, Koh, K, Imai, C, Yoshida, N, Koga, Y, Fujita, N, Saito, AM, Adachi, S, Ishii, E & Shimada, H 2019, 'Discontinuation of Tyrosine Kinase Inhibitor in Children with Chronic Myeloid Leukemia (JPLSG STKI-14 study)', Blood, vol. 134, no. 1. https://doi.org/10.1182/blood-2019-122623
Shima H, Kada A, Tanizawa A, Yuza Y, Watanabe A, Ito M et al. Discontinuation of Tyrosine Kinase Inhibitor in Children with Chronic Myeloid Leukemia (JPLSG STKI-14 study). Blood. 2019 Nov 13;134(1). https://doi.org/10.1182/blood-2019-122623
Shima, Haruko ; Kada, Akiko ; Tanizawa, Akihiko ; Yuza, Yuki ; Watanabe, Akihiro ; Ito, Masaki ; Uryu, Hideko ; Koh, Katsuyoshi ; Imai, Chihaya ; Yoshida, Nao ; Koga, Yuhki ; Fujita, Naoto ; Saito, Akiko M. ; Adachi, Souichi ; Ishii, Eiichi ; Shimada, Hiroyuki. / Discontinuation of Tyrosine Kinase Inhibitor in Children with Chronic Myeloid Leukemia (JPLSG STKI-14 study). In: Blood. 2019 ; Vol. 134, No. 1.
@article{86d2d93802004a73b7b9c74df3fe331b,
title = "Discontinuation of Tyrosine Kinase Inhibitor in Children with Chronic Myeloid Leukemia (JPLSG STKI-14 study)",
abstract = "DISCLOSURES: Kada: Bayer Yakuhin: Other: personal fees for a member of independent data monitoring committee of clinical trials, outside of the submitted work.. Imai:Juno Therapeutics: Patents & Royalties.",
author = "Haruko Shima and Akiko Kada and Akihiko Tanizawa and Yuki Yuza and Akihiro Watanabe and Masaki Ito and Hideko Uryu and Katsuyoshi Koh and Chihaya Imai and Nao Yoshida and Yuhki Koga and Naoto Fujita and Saito, {Akiko M.} and Souichi Adachi and Eiichi Ishii and Hiroyuki Shimada",
year = "2019",
month = "11",
day = "13",
doi = "10.1182/blood-2019-122623",
language = "English",
volume = "134",
journal = "Blood",
issn = "0006-4971",
publisher = "American Society of Hematology",
number = "1",

}

TY - JOUR

T1 - Discontinuation of Tyrosine Kinase Inhibitor in Children with Chronic Myeloid Leukemia (JPLSG STKI-14 study)

AU - Shima, Haruko

AU - Kada, Akiko

AU - Tanizawa, Akihiko

AU - Yuza, Yuki

AU - Watanabe, Akihiro

AU - Ito, Masaki

AU - Uryu, Hideko

AU - Koh, Katsuyoshi

AU - Imai, Chihaya

AU - Yoshida, Nao

AU - Koga, Yuhki

AU - Fujita, Naoto

AU - Saito, Akiko M.

AU - Adachi, Souichi

AU - Ishii, Eiichi

AU - Shimada, Hiroyuki

PY - 2019/11/13

Y1 - 2019/11/13

N2 - DISCLOSURES: Kada: Bayer Yakuhin: Other: personal fees for a member of independent data monitoring committee of clinical trials, outside of the submitted work.. Imai:Juno Therapeutics: Patents & Royalties.

AB - DISCLOSURES: Kada: Bayer Yakuhin: Other: personal fees for a member of independent data monitoring committee of clinical trials, outside of the submitted work.. Imai:Juno Therapeutics: Patents & Royalties.

UR - http://www.scopus.com/inward/record.url?scp=85074959207&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85074959207&partnerID=8YFLogxK

U2 - 10.1182/blood-2019-122623

DO - 10.1182/blood-2019-122623

M3 - Article

C2 - 31724002

AN - SCOPUS:85074959207

VL - 134

JO - Blood

JF - Blood

SN - 0006-4971

IS - 1

ER -

Access to Document